These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1494850)

  • 1. Potential for tumor markers as screening tools for early cancer diagnosis.
    Morton DL; Gupta RK
    Trans Assoc Life Insur Med Dir Am; 1992; 75():69-80. PubMed ID: 1494850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic diagnosis of cancer--tumor markers].
    Kawai T
    Gan No Rinsho; 1989 Jan; Spec No():13-8. PubMed ID: 2915470
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sense and nonsense of tumor markers in practice].
    Joss R; Cerny T
    Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigenic markers in the cytological diagnosis of human malignant neoplasms].
    Frank GA; Pugachev KK; Shabalova IP; Shimbireva IB
    Arkh Patol; 1990; 52(8):70-4. PubMed ID: 2281989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of immunohistochemistry in histological diagnosis].
    Hurlimann J
    Rev Med Suisse Romande; 1990 Jul; 110(7):597-602. PubMed ID: 2382067
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The footprints of cancer development: Cancer biomarkers.
    Ullah MF; Aatif M
    Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers in pancreatic cancer--current concepts.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemistry and histochemistry of new tumor-associated antigens and their relation to blood group substances].
    Vierbuchen M; Larena A; Hanisch FG; Uhlenbruck G
    Verh Dtsch Ges Inn Med; 1991; 97():420-49. PubMed ID: 1808924
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic cancer and tumor markers].
    Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
    Rinsho Byori; 1991 Jun; Suppl 89():58-72. PubMed ID: 1680205
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies for heterogeneous enzyme immunoassays for tumor markers.
    King WJ; Tomita JT; Dowell BL; Delfert DM
    Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
    [No Abstract]   [Full Text] [Related]  

  • 15. The monitoring of minimal residual disease in patients with malignant tumors.
    Reizenstein P
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():5-15. PubMed ID: 3074226
    [No Abstract]   [Full Text] [Related]  

  • 16. The monitoring of minimal residual disease in patients with malignant tumors.
    Reizenstein P
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):5-15. PubMed ID: 2472905
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers in human breast cancer].
    Takami H; Shikata J
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of multiple markers to enhance clinical utility.
    Mercer DW
    Immunol Ser; 1990; 53():39-54. PubMed ID: 2100569
    [No Abstract]   [Full Text] [Related]  

  • 20. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
    Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
    Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.